EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Trends in Proton‐Pump Inhibitor Use Among Danish Adults: A Nationwide Drug Utilization Study 2015–2023

Karoline M Lundgaard iD, Morten Ø Christiansen iD, Heidi Sonne iD, Katrine Mose iD, Nikolaj Nyland iD, Maja J L Andersen iD, Anton Pottegård iD

Basic & Clinical Pharmacology & Toxicology · 2025

DOI: 10.1111/bcpt.70057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Karoline M Lundgaard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Drug Utilization, Practice Patterns, Physicians'. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global increase in proton‐pump inhibitor (PPI) use has raised concerns about their appropriate use, particularly due to potential overprescription and associated adverse effects. This study examines PPI utilization patterns among Danish adults from 2015 to 2023 using the Danish nationwide health registries. We estimated the annual incidence rate (users per 100 person‐years) and monthly prevalence (proportion with a filled prescription or sufficient tablets). Treatment duration was assessed using the ‘proportion of patients covered’ and the Kaplan–Meier method. We also calculated the proportion of adults with concomitant use of ulcerogenic drugs over time. We identified 1 729 440 adults who filled at least one PPI prescription during 2015–2023. The prevalence increased from 7.0% in 2015 to 8.2% in 2023, while incidence rate remained stable at ~3 users per 100 person years. PPI use increased with age. Three years after initiation, 17% used PPIs, while 1.5% had remained on continuous treatment. In 2023, 50% of users had concomitant ulcerogenic drug use, a 3.2% increase since 2015. The prevalence of PPI use in Denmark has risen markedly reaching a high stable level, with a clear age‐dependent trend. Increased attention to appropriate PPI use is necessary to ensure rational prescribing and prevent potential overuse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsDrug UtilizationPractice Patterns, Physicians'HumansDenmarkFemaleMaleMiddle AgedAdultAgedYoung AdultRegistriesAged, 80 and overPrevalenceIncidenceAge FactorsAdolescent

Stichwörter der Autor:innen

consumptiondrug utilizationnationwideprescription registryproton‐pump inhibitor

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Karoline M Lundgaard, Morten Ø Christiansen, Heidi Sonne, Katrine Mose, Nikolaj Nyland, Maja J L Andersen, Anton Pottegård

Zitieren

APA

Lundgaard, K. M., Christiansen, M. Ø., Sonne, H., Mose, K., Nyland, N., Andersen, M. J. L., & Pottegård, A. (2025). Trends in Proton‐Pump Inhibitor Use Among Danish Adults: A Nationwide Drug Utilization Study 2015–2023. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70057

Vancouver

Lundgaard KM, Christiansen MØ, Sonne H, Mose K, Nyland N, Andersen MJL, et al. Trends in Proton‐Pump Inhibitor Use Among Danish Adults: A Nationwide Drug Utilization Study 2015–2023. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70057

BibTeX
@article{Lundgaard2025,
  author = {Lundgaard, Karoline M and Christiansen, Morten Ø and Sonne, Heidi and Mose, Katrine and Nyland, Nikolaj and Andersen, Maja J L and Pottegård, Anton},
  title = {Trends in Proton‐Pump Inhibitor Use Among Danish Adults: A Nationwide Drug Utilization Study 2015–2023},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  doi = {10.1111/bcpt.70057}
}
Kostenlos starten →